NEW YORK (GenomeWeb News) — The University of Pittsburgh Medical School will serve as the alpha test site for Wafergen Biosystem’s real-time PCR system, Wafergen said today.

 

Through a research collaboration with a team led by Department of Medicine Chairman Steven Shapiro, the school will use the WaferGen SmartChip Real-Time PCR System in its efforts to identify biomarkers that are therapeutically useful for chronic obstructive pulmonary disease and for lung cancer.